Shares of Cellcom Israel, Ltd. (NYSE:CEL) have been assigned an average broker rating score of 5.00 (Strong Sell) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong sell rating.

Zacks has also given Cellcom Israel an industry rank of 208 out of 265 based on the ratings given to its competitors.

A number of brokerages recently weighed in on CEL. BidaskClub downgraded Cellcom Israel from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Citigroup Inc. downgraded Cellcom Israel from a “neutral” rating to a “sell” rating in a research report on Wednesday, July 26th.

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in Cellcom Israel by 8.7% during the second quarter. Vanguard Group Inc. now owns 1,016,527 shares of the technology company’s stock worth $9,800,000 after buying an additional 81,105 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Cellcom Israel by 4.1% during the second quarter. Dimensional Fund Advisors LP now owns 78,732 shares of the technology company’s stock worth $759,000 after buying an additional 3,102 shares in the last quarter. Eagle Global Advisors LLC lifted its position in Cellcom Israel by 15.4% during the second quarter. Eagle Global Advisors LLC now owns 75,000 shares of the technology company’s stock worth $719,000 after buying an additional 10,000 shares in the last quarter. Credit Suisse AG lifted its position in Cellcom Israel by 61.6% during the first quarter. Credit Suisse AG now owns 61,754 shares of the technology company’s stock worth $635,000 after buying an additional 23,544 shares in the last quarter. Finally, Bank of America Corp DE lifted its position in Cellcom Israel by 153.2% during the first quarter. Bank of America Corp DE now owns 47,781 shares of the technology company’s stock worth $492,000 after buying an additional 28,910 shares in the last quarter. Hedge funds and other institutional investors own 5.53% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Zacks: Cellcom Israel, Ltd. (CEL) Given Consensus Recommendation of “Strong Sell” by Analysts” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/11/03/zacks-cellcom-israel-ltd-cel-given-consensus-recommendation-of-strong-sell-by-analysts.html.

About Cellcom Israel

Cellcom Israel Ltd. is engaged in the provision of cellular telephone services. The Company offers fixed-line services. The Company operates in two segments: Cellular and Fixed-line. The cellular segment includes the cellular communications services, end user cellular equipment and supplemental services.

Get a free copy of the Zacks research report on Cellcom Israel (CEL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cellcom Israel Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellcom Israel Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.